Oxford Asset Management’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
ECM
N
Oxford Asset Management's ANGO Position: Q2 2024 in Review
Oxford Asset Management sold out of AngioDynamics (ANGO) in Q2 2024, closing a stake of 20,688 shares — an estimated $121K sold.
Oxford Asset Management first reported a position in ANGO in Q3 2013 and held it in 22 quarters. The position peaked at $4.39M in Q3 2016. 139 funds tracked by Wall St. Rank hold ANGO as of Q2 2024.
- Oxford Asset Management reported no remaining AngioDynamics position as of Q2 2024 after selling out during the quarter.
- Oxford Asset Management sold 20,688 AngioDynamics shares in Q2 2024, an estimated $121K.
- Oxford Asset Management first reported a position in AngioDynamics in Q3 2013 and held it in 22 quarters.
- Oxford Asset Management's AngioDynamics position peaked at $4.39M in Q3 2016.
- 139 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2024.
Based on Oxford Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.